Cormedix Inc. Announces Presentation at Conference Showing Mortality Risk and Complications in Patients Experiencing Catheter Related Blood Stream Infections
BERKELEY HEIGHTS, N.J., Dec. 06, 2022 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical…
SeoulCeuticals Publishes First Official Layering Guide for Volufiline Snail Mucin Serum, Identifying Retinol Sequencing as the Cause of Preventable Irritation for Millions of Users